All clinical trials are reviewed by an Institutional Review Board (IRB) to protect the rights and safety of people who join. But some trials stand out because they’re doing more for patients. Our review committee of patients and researchers helped identify some trials that are going above and beyond. They are our featured trials.
- A drug, apraglutide, to treat acute graft-versus-host disease (GVHD) that has not gotten better with treatment (refractory)To find out if apraglutide is safe and works well to treat GVHD that is refractory
- Engineered donor graft (donor cells treated in lab) for people getting allogeneic (cells from a donor) blood or marrow transplant (BMT) to treat blood cancerTo find out if an engineered donor graft is safe and works well to treat blood cancer for people getting an allogeneic BMT